Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug combination for treatment of cerebrovascular diseases and preparation method thereof

A technology for cerebrovascular disease and composition, applied in the field of medicine, can solve the problem of not being able to treat both the symptoms and root causes, and achieve the effect of preventing pain

Inactive Publication Date: 2017-11-10
李金华
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Some existing medicines and methods for treating cerebral infarction, cerebral hemorrhage and other cerebrovascular diseases, as well as preventing comorbidity or sequelae, apoplexy, etc. due to the above-mentioned cerebrovascular diseases, all have deficiencies and cannot achieve the effect of treating both symptoms and root causes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0026] The present invention also provides a preparation method of the above-mentioned pharmaceutical composition. The first raw material drug is mixed, pulverized, mixed with water and decocted for at least 20 minutes to obtain a filtrate.

[0027] When the above pharmaceutical composition contains the second raw material, the first raw material and the second raw material are mixed according to parts by weight, pulverized, mixed with water and decocted for at least 20 minutes to obtain a filtrate.

[0028] Wherein, it is preferable to pass through a 20-mesh sieve after the above pulverization, and then decoct the under-sieve for at least 20 minutes, such as 30 minutes, 50 minutes, 60 minutes, etc., to obtain a filtrate.

[0029] Preferably, the undersieve is mixed with water, soaked for 20-40 minutes, and then decocted, so as to save subsequent decoction time. Wherein, decoction can be carried out once, also can carry out step by step, for example, decoct for the first time,...

Embodiment 1

[0032] A pharmaceutical composition for treating cerebrovascular diseases, which is prepared by the following method:

[0033] The first raw drug is mixed, pulverized, mixed with water and decocted for 40 minutes to obtain a filtrate.

[0034] Wherein, the first raw material medicine includes: 15 parts by weight of sumac; 15 parts by weight of salvia miltiorrhiza; 6 parts by weight of leech; 10 parts by weight of earthworm;

Embodiment 2

[0036] A pharmaceutical composition for treating cerebrovascular diseases, which is prepared by the following method:

[0037] The first raw drug is mixed, pulverized, mixed with water and decocted for 20 minutes to obtain a filtrate.

[0038] Wherein, the first raw material medicine includes: 14 parts by weight of sumac; 16 parts by weight of salvia miltiorrhiza; 6 parts by weight of leech; 9 parts by weight of earthworm; 5 parts by weight of astragalus;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a drug combination for treatment of cerebrovascular diseases and a preparation method thereof, and relates to the field of medicine. The drug combination comprises first crude drugs. The first crude drugs comprise, by weight, 14-16 parts of sappanwood, 14-16 parts of the root of red-rooted salvia, 4-6 parts of hirudo, 9-12 parts of lumbricus and 6-9 parts of stir-baked squama manitis. The brain diseases like cerebral infarction and cerebral hemorrhage can be effectively treated or prevented, and the complications or sequelae caused by the diseases are prevented. The preparation method of the drug combination includes the steps that the first crude drugs are mixed and smashed by weight and then are mixed with water to be decocted for at least 20 minutes, and filter liquor is obtained. The method is simple and controllable, convenient to operate and capable of achieving mass production.

Description

technical field [0001] The invention relates to the field of medicine, and in particular to a pharmaceutical composition for treating cerebrovascular diseases and a preparation method thereof. Background technique [0002] Some existing cerebrovascular diseases such as the treatment of cerebral infarction and cerebral hemorrhage, as well as the medicines and methods for preventing comorbidities or sequelae, apoplexy, etc. due to the above-mentioned cerebrovascular diseases, all have deficiencies and cannot achieve the effect of treating both symptoms and root causes. Contents of the invention [0003] The purpose of the present invention is to provide a pharmaceutical composition for the treatment of cerebrovascular diseases, which has the effects of nourishing qi and activating blood circulation, removing blood stasis and dredging collaterals, promoting blood circulation and resolving phlegm, dispelling wind and reducing blood lipids, etc., and can effectively treat or pre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61K36/888A61K36/899A61P9/10A61P7/04A61P7/02A61P3/06A61P29/00A61P25/00A61P25/20A61P1/08A61K35/62A61K35/36A61K35/64A61K35/648A61K35/646A61K33/26
CPCA61K36/8888A61K36/899A61K33/26A61K35/36A61K35/62A61K35/63A61K35/646A61K35/648A61K36/185A61K36/21A61K36/232A61K36/286A61K36/31A61K36/48A61K36/481A61K36/482A61K36/486A61K36/537A61K36/736A61K36/752A61K36/888A61K2236/331A61K2300/00
Inventor 李金华
Owner 李金华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com